Section 906 Sarbanes-Oxley Certification by CEO and CFO of Nabi Biopharmaceuticals for Q2 2002
Summary
This document is a certification by the Chief Executive Officer and Chief Financial Officer of Nabi Biopharmaceuticals, confirming that the company's quarterly report for the period ending June 30, 2002, complies with federal securities laws and fairly presents the company's financial condition. The certification is made to fulfill requirements under Section 906 of the Sarbanes-Oxley Act of 2002. It is not considered a filing for liability purposes under the Securities Exchange Act or other laws.
EX-10.51 3 g77709exv10w51.txt CERTIFICATION PURSUANT SECTION 906 EXHIBIT 10.51 STATEMENT UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 The undersigned officers of Nabi Biopharmaceuticals (the "Company") hereby certify that, as of the date of this statement, the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2002 (the "Report") fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of the Company as of and for the three- and six-month periods ended June 29, 2002. The purpose of this statement is solely to comply with Title 18, Chapter 63, Section 1350 of the United States Code, as amended by Section 906 of the Sarbanes-Oxley Act of 2002. This statement is not "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Act or any other federal or state law or regulation. Date: August 12, 2002 /s/ David J.Gury ----------------------------------------- Name: David J. Gury Title: Chief Executive Officer Date: August 12, 2002 /s/ Mark L. Smith ----------------------------------------- Name: Mark L. Smith Title: Chief Financial Officer
